New scan could spot hidden cancer spread
NCT ID NCT04621435
Summary
This early-stage trial is testing a new imaging tracer called FAP-2286 to see if it can better detect cancer that has spread (metastasized) in people with solid tumors. The study will enroll about 191 adults with cancers like breast, prostate, pancreatic, and colon cancer. Researchers will inject a small amount of a radioactive tracer and use a PET scan to see if it lights up cancer cells, aiming to improve detection compared to current imaging methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.